Background illustration for clinical trials search

Paid Clinical Trials Eugene

Discover 156 paid clinical trials in Eugene, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

for
Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms,
Location: Eugene OR, San Francisco CA, Palo Alto CA,
Sponsor: Corcept Therapeutics

Sex: Female

Age: 18+

Code: NCT06906341

Phase 2, Recruiting

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

for
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma,
Location: Eugene OR, Portland OR, Seattle WA, Lewiston ID,
Sponsor: Sameek Roychowdhury

Sex: All

Age: 18+

Code: NCT06906562

Phase 2, Recruiting

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

for
Age-related Macular Degeneration (AMD), Geographic Atrophy (GA)
Location: Eugene OR, Portland OR, Spokane WA, Sacramento CA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 50 - 70+

Code: NCT06541704

Phase 3, Recruiting

A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes

for
Higher-risk Myelodysplastic Syndromes
Location: Eugene OR, Los Angeles CA, Aurora CO, Dallas TX,
Sponsor: Akeso

Sex: All

Age: 18+

Code: NCT06196203

Phase 2, Recruiting

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer,
Location: Eugene OR, Tacoma WA, Seattle WA, San Francisco CA,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06343402

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

for
Ovarian Cancer
Location: Eugene OR, Portland OR, Billings MT, Los Angeles CA,
Sponsor: Incyte Corporation

Sex: Female

Age: 18+

Code: NCT07214779

Phase 3, Recruiting

Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer (NSCLC)
Location: Eugene OR, West Haven-Sylvan OR, Portland OR,
Sponsor: Genmab

Sex: All

Age: 18+

Code: NCT07288177

Phase 2, Recruiting

A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer

for
Low Grade Serous Ovarian Cancer
Location: Eugene OR, Portland OR, Vancouver, Sacramento CA,
Sponsor: Verastem, Inc.

Sex: Female

Age: 18+

Code: NCT06072781

Phase 3, Recruiting

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Eugene OR, Tacoma WA, Seattle WA, Salt Lake City UT,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06479135

Phase 3, Recruiting

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

for
Melanoma
Location: Eugene OR, Portland OR, Kennewick WA, Issaquah WA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06246916

Phase 3, Recruiting

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

for
High Grade Epithelial Ovarian Cancer,
Location: Eugene OR, Portland OR, Everett WA, Santa Rosa CA,
Sponsor: Genmab

Sex: All

Age: 18+

Code: NCT05579366

Phase 1, Phase 2, Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

for
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer,
Location: Eugene OR, Salt Lake City UT, Billings MT,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06881784

Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Eugene OR, Walnut Creek CA, San Francisco CA, Calgary,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06824467

Phase 3, Recruiting

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

for
Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute,
Location: Eugene OR, Salt Lake City UT, Calgary, Newport Beach CA,
Sponsor: Sumitomo Pharma America, Inc.

Sex: All

Age: 12+

Code: NCT04988555

Phase 1, Phase 2, Recruiting

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

for
Multiple Myeloma
Location: Eugene OR, Denver CO, Tucson AZ, Minneapolis MN,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 18+

Code: NCT05972135

Phase 2, Recruiting

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

for
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer,
Location: Eugene OR, Reno NV, Phoenix AZ, Lone Tree CO, Tucson AZ,
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

Sex: Female

Age: 18+

Code: NCT05128825

Phase 2, Recruiting

Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer

for
Metastatic Pancreatic Cancer
Location: Eugene OR, Los Angeles CA, Tyler TX, Pittsburgh PA,
Sponsor: Cantex Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT05766748

Phase 1, Phase 2, Recruiting

A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)

for
Chronic Myeloid Leukemia, Chronic Phase,
Location: Eugene OR, Portland OR, Seattle WA, Salt Lake City UT,
Sponsor: Terns, Inc.

Sex: All

Age: 18+

Code: NCT06163430

Phase 1, Phase 2, Recruiting

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

for
Large B-cell Lymphoma
Location: Eugene OR, Portland OR, Seattle WA, Sacramento CA,
Sponsor: Allogene Therapeutics

Sex: All

Age: 18+

Code: NCT06500273

Phase 2, Recruiting

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

for
Endometrial Cancer
Location: Eugene OR, Portland OR, Vallejo CA, Las Vegas NV,
Sponsor: Kartos Therapeutics, Inc.

Sex: Female

Age: 18+

Code: NCT05797831

Phase 2, Phase 3, Recruiting